The Bosniak classification system is the gold standard used by radiologists and urologists to determine the likelihood of malignancy in renal (kidney) cystic masses. It helps doctors decide whether a cyst can be safely ignored, needs monitoring, or requires surgical intervention.
| Category | Description | Risk of Malignancy | Management |
| I | Simple benign cyst. Hairline thin wall, no septa, calcifications, or solid components. | ~0% | No follow-up needed. |
| II | Benign cystic lesion. May have a few “hairline” thin septa or fine calcifications. | ~0% | No follow-up needed. |
| IIF | “Follow” category. Increased number of thin septa or minimal smooth thickening of the wall/septa. | ~5–10% | Serial imaging (CT/MRI) to check for stability. |
| III | Indeterminate. Thick or irregular walls/septa with “measurable” enhancement. | ~50% | Surgery (Partial nephrectomy) or ablation. |
| IV | Clearly Malignant. Features of Category III plus independent enhancing soft-tissue nodules. | ~90% | Surgery is almost always indicated. |
When evaluating these cysts, doctors look for three main “red flags” on a CT or MRI:
Septations: Are there “walls” inside the cyst? The more septa there are, and the thicker they are, the higher the grade.
Calcification: While not always a sign of cancer, irregular or heavy calcification can push a cyst into the IIF or III category.
Enhancement: This is the most critical factor. If the cyst wall or septa “light up” after injecting contrast dye, it indicates blood flow, which is a hallmark of a tumour.
The 2019 update was specifically designed to be more formal about what constitutes a “nodule” versus “thickening.” By tightening these definitions, the medical community has been able to move many cysts that were previously labeled Category III (surgery) into Category IIF (observation), saving patients from invasive procedures.
Note: This classification is specifically for cystic masses. Solid kidney masses are evaluated differently, as they carry a much higher baseline risk of being Renal Cell Carcinoma (RCC).
Dialysis vs. Kidney Transplant: 5 Pros and 5 Cons For patients reaching End-Stage Renal Disease (ESRD or CKD5), the transition to Renal Replacement Therapy is a major life milestone. There are g...
Is CKD a disease or normal ageing? (does it even exist?) As you can imagine this a deliberately controversial article. Here goes. This article is mainly for health professionals. Key Points CKD stages...
How Often Should GFR Be Monitored in CKD? Keep track of your kidney data with PKB Monitoring kidney function is a key part of managing chronic kidney disease (CKD). One of the most important markers i...
What are the Pros and Cons of Dietary Management of CKD? Medically reviewed by Dr. Andrew Stein, Consultant Nephrologist: Last updated May 2026 Whilst dietary strategies are common pillars o...
